Managing Treatment-Experienced Patients With Multidrug Resistance: Emerging Options and Strategies

Join Eric S. Daar, MD, and Daniel R. Kuritzkes, MD, as they review best practices in identifying and selecting optimal ART regimens for patients with multidrug-resistant HIV. Hear their take on what you should be doing in the clinic and get answers to your questions at this interactive, CME/CE-certified symposium.

Agenda

12:00 PM Registration and Buffet Meal

12:15 PM Program Overview

12:25 PM Multidrug-Resistant HIV: The Scope of the Problem

  • Prevalence of MDR HIV in the US
  • Identification of patients with MDR HIV
  • Principles for constructing ART regimens for patients with MDR HIV

12:45 PM Case Studies

  • Identifying and selecting optimal ART regimens for multidrug-resistant HIV patients
  • Emerging investigational agents for treating MDR HIV
  • Which patients should be referred to specialists?

1:15 PM Question and Answer Session

1:30 PM Adjournment

Events

Date / Time
Event Details

Faculty

Faculty
Eric Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Faculty
Daniel Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

CME

Program Overview
You are invited to attend a live, interactive CME/CE-certified symposium in which expert faculty will discuss key strategies to identify and manage highly treatment–experienced patients with multidrug-resistant HIV.

Goal Statement
The goal of this activity is to improve participants’ competence in identifying and treating patients with multidrug-resistant HIV. 

Target Audience 
This activity is intended for physicians, registered nurses, pharmacists, and other healthcare professionals involved in the care of patients infected with HIV.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Implement practical strategies to identify multidrug-resistant HIV among highly treatment–experienced patients
  • Apply best practices for the selection of optimal individualized regimens for treatment-experienced patients
  • Appraise emerging options for the management of patients with multidrug-resistant HIV who cannot achieve virologic suppression using currently approved agents

Accreditation

Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Clinical Care Options, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation
This educational activity for 1.2 contact hour is provided by Postgraduate Institute for Medicine.

Accreditation Statement
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 4 weeks.

ACPE logo

Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hour (0.125 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - ACPE UAN is 0809-9999-17-504-L02-P)

Type of Activity: Application

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.